Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity.

MLA

Pyle, Chloe J., et al. “Enhanced IL-2 in Early Life Limits the Development of TFH and Protective Antiviral Immunity.” The Journal of Experimental Medicine, vol. 218, no. 12, Dec. 2021. EBSCOhost, https://doi.org/10.1084/jem.20201555.

APA

Pyle, C. J., Labeur-Iurman, L., Groves, H. T., Puttur, F., Lloyd, C. M., Tregoning, J. S., & Harker, J. A. (2021). Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity. The Journal of Experimental Medicine, 218(12). https://doi.org/10.1084/jem.20201555

Chicago

Pyle, Chloe J, Lucia Labeur-Iurman, Helen T Groves, Franz Puttur, Clare M Lloyd, John S Tregoning, and James A Harker. 2021. “Enhanced IL-2 in Early Life Limits the Development of TFH and Protective Antiviral Immunity.” The Journal of Experimental Medicine 218 (12). doi:10.1084/jem.20201555.